enrichment) (Tuerk & MacDougal-Waugh, 1993) . Although numerous reports have detailed the selection of aptamers against different bacterial species (Cao et al., 2009; Chen, Zhou, Luo, Mohammed, & Zhang, 2007; Hamula, Le, & Li, 2011) , few studies screening aptamers for their clinical value and potential use to inhibit the morphology switching that occurs during C. albicans-related infections have been reported.
In this study, we used the SELEX technique to select RNA aptamers with high affinity and specificity for C. albicans yeast cells.
Furthermore, we used an aptamer-linked immobilized sorbent assay (ALISA) to demonstrate the potential use of high-affinity aptamers in quantitative determination of C. albicans. Finally, we investigated the ability of the aptamers to inhibit C. albicans growth in vitro.
| MATERIAL S AND ME THODS

| Preparation of cells for aptamer selection
Candida albicans (ATCC 10231) was used as a targeted aptamer ligand, while Saccharomyces cerevisiae (ATCC 9763) was used for counter selection. For the binding specificity test, we used Streptococcus mutans (Xc), a stock culture of C. albicans that was previously isolated in our dental hospital (Universitas Indonesia) using Chromogenic Candida Agar (CCA; Oxoid, Basingstoke, UK) (Ghelardi et al., 2008) , and S. cerevisiae. All microorganisms were maintained and propagated as described elsewhere (Bachtiar et al., 2014; Shibata, Kawada, Nakano, Toyoshima, & Yamashita, 2005; Vazquez-Reyna, Balcazar-Orozco, & Flores-Carreon, 1993) . To obtain budding yeast cells of C. albicans and S. cerevisiae, we used YPD (1% yeast extract, 2% peptone, 2% glucose) broth shaking at 30°C that was inoculated with C. albicans or S. cerevisiae that had been grown overnight on a YPD agar plate under aerobic conditions. The resulting budding yeasts were washed twice in phosphate-buffered saline (PBS, Oxoid Ltd, Basingstoke, UK) and resuspended in RPMI 1640 supplemented with L-glutamine and buffered with MOPS (Sigma, St Louis, MO, USA). The yeast density was measured by using a hemocytometer and adjusted for the SELEX procedure, while the bacterial number was counted by the plating method.
| In vitro selection of RNA aptamers for C. albicans ATCC 10231
A library of RNAs containing 40-nt randomized central sequences flanked by defined primer binding sites with the
UAUGUGCGUCUACAUCUAGACUCAU-3′ (84 nt) was generated as previously described (Srisawat & Engelke, 2001 ) with a calculated library complexity of 1 × 10 13 different RNA sequences. The selection conditions of the SELEX process are shown in Table 1 (Srisawat & Engelke, 2001) . To enrich the aptamers specific to C. albicans, a counterselection step was included at rounds 3, 5, and 10 using 5 × 10 7 S. cerevisiae cells. The RNAs unbound after S. cerevisiae binding were used in the binding reaction with C. albicans as described above.
After 11 rounds of selection, the RNAs were cloned into a plasmid using a TOPO TA Cloning Kit, and the ligated plasmids were transformed into One Shot ® Top 10 Escherichia coli (Invitrogen, Carlsbad, CA). The plasmids containing the aptamers were purified using a QIAprep Miniprep Kit (Qiagen, Hilden, Germany), and the ap- 
| Aptamer-linked immobilized sorbent assay
The binding affinity of the selected aptamers was measured using an ALISA. To do this, 96-well microtiter plates (Iwaki, Tokyo, Japan)
were coated with 50 μl of mouse anti-human C. albicans monoclonal antibody (U.S. Biological, Swampscott, Mass) diluted to 1 μg/ml in coating buffer (50 mmol/L Na 2 CO 3 , pH 9.6) and incubated overnight at 4°C. The plates were washed twice with PBST (50 mmol/L phosphate-buffered saline, pH 7.2 containing 0.05% Tween 20)
and blocked with 100 ml of 1% BSA (Sigma, MA, USA) in PBST for 90 min at room temperature (RT). After washing, various concentrations of the C. albicans preparation in PBST (100 μl, triplicate), ranging from 50 to 5,000 cells/ml, were incubated for 1 hr at RT by gentle shaking in 100 μl of binding buffer. After the designated time, the unbound target was removed, and the plates were washed twice with PBST containing 0.1% Tween 20. Subsequently, 100 μl (100 μg/ml) of the biotinylated aptamer that was prepared as described elsewhere (Tsuji et al., 2009 ) was added into each well, and binding was allowed to proceed protected from light for 1 hr at RT.
The unbound materials were removed by washing with washing buffer (three times). Finally, 100 μl of a 1:1,000 dilution of a solution of streptavidin conjugated to horseradish peroxidase (HRP) was added to the individual wells. Following a 30-min incubation on a shaking platform at RT, wells were washed twice with PBST and developed using ABTS as a substrate (Sigma, MA, USA). The reaction was stopped with 100 ml of 0.25 M H 2 SO 4 , absorbance was measured at 450 nm using a microplate reader (BioRad, USA), and washing buffer was used as a background control. The same procedure was used for enzyme-linked immunosorbent assays (ELISA). However, the biotinylated aptamer used in the ALISA was replaced by biotinylated polyclonal anti-C. albicans antibodies in the ELISA.
| The effect of RNA aptamers on biofilm formation
Biofilm formation assays were performed as previously described (Bachtiar et al., 2014) . Briefly, 100 μl containing 1.8 × 10 5 yeast cells of C. albicans from overnight culture at 35°C was aliquoted into microtiter plates. Three different concentrations of each tested aptamer in buffer (1 ng/μl, 10 ng/μl, and 10 ng/μl) were then added into separate wells, and the plates were incubated at 37°C in 5% CO 2 in air for 90 min with gentle shaking. To promote biofilm formation, the wells were treated with 150 μl of fresh yeast nitrogen base (Sigma-Aldrich) medium without aptamer, and the culture period was lengthened to 24 hr. Candida albicans growth was determined by evaluating the metabolic activity of growing C. albicans using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reagent (Sigma-Aldrich).
Candida albicans biofilms with PBS (pH 7.2) added instead of aptamer were included to serve as negative controls. Statistical significance for all experiments was determined by pairwise comparison by t test using GraphPad Prism 7.0 software. p < 0.05 was considered statistically significant.
| RE SULTS
| In vitro selection of RNA aptamers against yeast cells of C. albicans
In this study, q-PCR was used to monitor the enrichment progress of RNA aptamers. To decrease nonspecific binding of RNA, the experimental conditions in each selection round (Table 1) From the first to fifth rounds of the SELEX process, the components of the library that were enriched included specific and nonspecific binders. However, when the counterselection step was performed at the fifth round, the retention rate decreased gradually from the sixth to 10th rounds. We found that at the 11th round, the enrichment of the RNAs capable of binding to the target C. albicans increased significantly compared with the fifth round RNAs and the original library RNAs (data not shown). Therefore, the PCR products from round 11 were cloned to characterize each aptamer, and the randomized regions of the aptamers are shown in Figure 1a . They do not exhibit any consensus sequences and are unique except for Caapt-1 and Ca-apt-12, which were identified four and two times during the screening, respectively. Their preferential retention during selection suggests that they might have high affinity toward the target cells. The predicted secondary structures of both aptamers are shown in Figure 1b . Interestingly, the length of the randomized region of Ca-apt-1 [41 nucleotide (nt)] was longer than that of the original 40-nt pool RNAs. Such changes may occur either during reverse transcription or PCR steps in multiple rounds of SELEX (Doudna, Cech, & Sullenger, 1995; Takemura et al., 2006; Ye et al., 2014) .
Next, the aptamers were screened for their binding to the target C. albicans. As expected, only the Ca-apt-1 and Ca-apt-12 aptamers demonstrated significantly higher binding percentages than the negative control RNA, which is a clone randomly chosen from the original RNA library (Figure 2a) . Therefore, these aptamers were chosen for subsequent characterization.
| Binding specificity test
To test the specificity of the aptamers and their binding to various targets, that is, C. albicans strains, either from the ATCC or a clinical specimen, S. cerevisiae, and S. mutans, was evaluated. As shown in Figure 2b To confirm the results and to test whether the aptamers can be used in diagnostics for C. albicans, we evaluated the aptamers ability to detect C. albicans using the ALISA method. The results showed that both Ca-apt-1 and Ca-apt-12 can detect C. albicans at concentrations ranging from 50 to 5,000 cells/ml, and the ALISA performance is comparable to that of the ELISA method using C. albicans-specific antibodies (Figure 2c ).
| Biofilm inhibition assay
The RNAs from the original library, round 11 RNAs, nonbinding RNAs, Ca-apt-1, and Ca-apt-12 were preincubated with C. albicans yeast The specificity of Ca-apt-1 and Ca-apt-12 was tested using either the target C. albicans strain or a clinical strain isolated from the oral cavity, a related yeast strain Saccharomyces cerevisiae, and Streptococcus mutans. The aptamer-linked immobilized sorbent assay (ALISA) using both aptamers is shown and compared with an ELISA using antibodies against C. albicans. The plots show the mean values, and an error bar represents the standard error of the mean (SEM). An asterisk indicates a statistically significant difference compared with the nonbinding RNAs using an unpaired t test (p < 0.05) cells before the biofilm was allowed to form. As shown in Figure 3a, the MTT assay results after 24 hr of biofilm growth demonstrate that the presence of the round 11 RNA and the Ca-apt-1 aptamer can cause a significant reduction in cell viability compared with that of the untreated group (p < 0.05). Moreover, there was a decrease in hyphal formation from yeast cells treated with the Ca-apt-1 aptamer compared with the untreated or library RNA-treated group, as observed under a light microscope (Figure 3b) . Interestingly, the Caapt-12 aptamer did not seem to affect biofilm formation, although it demonstrates binding affinity to C. albicans, as shown by ALISA (Figure 2c) . Moreover, incubation of C. albicans during the early stage of biofilm formation with Ca-apt-1 at concentrations as low as 1 ng/ μl was sufficient to inhibit viability and hyphal formation.
| D ISCUSS I ON
Candida albicans is the most common fungus causing oral candidiasis and is involved in the pathogenesis of early childhood caries (Falsetta et al., 2014) . However, no vaccine against this oral opportunistic pathogen is currently available. Thus, effective strategies for detecting and inhibiting Candida infection are needed.
Aptamers have been reviewed in detail as highly sensitive and specific ligands to detect pathogens (Torres-Chavolla & Alocilja, 2009). In this study, whole yeast cells of C. albicans strain ATCC 10231 were used as the target of RNA aptamer selection, as this may generate multiple targets in parallel (Shangguan et al., 2008) toward C. albicans cell surface molecules. Using whole-cell targets in the SELEX process can be faster, easier, and more reproducible than using other targets (Guo, Lin, Zhang, Simon, & Kushner, 2009 ).
In addition, when using the whole-cell SELEX method, it is not necessary to isolate and purify a single target protein, which might change the presentation of the target molecule compared to an intact, live, bacterial cell (Dwivedi, Smiley, & Jaykus, 2010) . Thus, this study showed that using the whole cell as a targeted ligand in the SELEX procedure has the potential to result in aptamers with binding affinity for targets on the cell in their native conformations.
In the current study, we used q-PCR to monitor library enrichment after each selection cycle, showing relatively increasing amounts of RNA binding that reached a maximum in the 11th round. To increase aptamer binding, we used a relatively low number of C. albicans cells, as studies have shown that compared with using a large amount of target, using small amounts of target increases the success of the selection and often results in higher-affinity aptamers (Chen et al., 2007) .
When the specificities of our samples were compared, our data showed that the Ca-apt-1 aptamer bound to only C. albicans, whereas the Ca-apt-12 aptamer can also bind to the related yeast species S. cerevisiae and the oral bacterium S. mutans, which has a symbiotic relationship with C. albicans (Falsetta et al., 2014) . As this study cannot determine the target molecule of the aptamer, we speculated that some of the potential targets of Ca-apt-12 are mannoproteins, immunodominant outer cell wall components of C.
albicans (Lopez-Ribot, Casanova, Murgui, & Martinez, 2004) . These glycoproteins mediate C. albicans-S. mutans interplay in plaque biofilm (Bachtiar & Bachtiar, 2018; Hwang et al., 2017) , and they have a critical role in the pathogenesis of early childhood caries . However, additional studies are required to identify the possible targets of both aptamers.
F I G U R E 3
The effect of the Candida albicans-specific aptamers on C. albicans biofilm formation. (a) C. albicans viability was determined after 24 hr of growth using the MTT assay in the presence of the RNAs from the original library, round 11, nonbinding RNAs, Ca-apt-1, and Ca-apt-12 at a concentration of 1 ng/μl. The plots show the mean values of the relative viability compared to the untreated control, and an error bar represents the standard error of the mean. An asterisk indicates a statistically significant difference compared with the untreated control using an unpaired t test (p < 0.05). The aptamers were further tested for their effects on C. albicans biofilm formation, which is considered to contribute to the virulence characteristics of C. albicans (Chandra et al., 2001) .We found that the Ca-apt-1 has the ability to interfere with C. albicans biofilm formation at the intermediate stage (24 hr) (Bachtiar, Dewiyani, Akbar, & Bachtiar, 2016) because the aptamer must act at the earliest stage of biofilm formation, which was set at 90 min in our experiment. We hypothesized that the effects of the Ca-apt-1 aptamer on biofilm formation might be physicochemical in nature or due to direct contact between the aptamer and the fungus, as shown in this study by a binding affinity test using an ALISA. However, in this study, we cannot explain the mechanisms by which the aptamer interferes with biofilm formation. Thus, further studies are necessary.
In conclusion, in this study, two candidate RNA aptamers, Caapt-1 and Ca-apt-12, were obtained through the SELEX method.
The Ca-apt-1 aptamer binds specifically to C. albicans and possesses the ability to inhibit the fungus as it develops as a biofilm, whereas
Ca-apt-12 shows cross-binding with S. cerevisiae and S. mutans and does not affect biofilm formation. Additional studies are necessary to identify the aptamer targets and to explore the potential applications of these aptamers in clinical settings. 
ACK N OWLED G EM ENTS
CO N FLI C T O F I NTE R E S T
The author(s) declare no financial or commercial conflicts of interest.
AUTH O R S CO NTR I B UTI O N
BMB and CS designed, coordinated, and performed the experiments, as well as drafted the manuscript. EWB and CS analysed the data. All authors read and approved the manuscript.
E TH I C S S TATEM ENT
None declared.
DATA ACCE SS I B I LIT Y
All data are included in the manuscript. Raw data are available on request.
O RCI D
Boy M. Bachtiar https://orcid.org/0000-0002-5286-2804
